RBP4/Retinol-Binding Protein 4 Antibody (RBP4/4046) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-24345PCP
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Monoclonal Mouse IgG2c Kappa Clone # RBP4/4046
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for RBP4/Retinol-Binding Protein 4 Antibody (RBP4/4046) [PerCP]
Immunogen
Recombinant fragment (around aa29-148) of human RBP4/Retinol-Binding Protein 4 protein (exact sequence is proprietary)
Localization
Secreted.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2c Kappa
Applications for RBP4/Retinol-Binding Protein 4 Antibody (RBP4/4046) [PerCP]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: RBP4/Retinol-Binding Protein 4
Alternate Names
RetinolBinding Protein 4
Gene Symbol
RBP4
Additional RBP4/Retinol-Binding Protein 4 Products
Product Documents for RBP4/Retinol-Binding Protein 4 Antibody (RBP4/4046) [PerCP]
Product Specific Notices for RBP4/Retinol-Binding Protein 4 Antibody (RBP4/4046) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...